AUS
NZ
UK
CA
USA
IND
Papyrus Australia Limited (ASX:PPY) has filed late change-of-director interest notices confirming that directors Al Jawhari, Brad Lemmon, and Arthur Stavrou acquired additional ordinary shares and options on 29 June 2026. This followed shareholder approval granted at an Extraordinary General Meeting held on 24 June 2026. The delayed lodgement was due to an administrative oversight in meeting ASX notification deadlines. The company has since enhanced its internal controls to prevent future delays in reporting director interests.
Key Highlights
- Papyrus Australia Limited (ASX:PPY), headquartered in Wayville, South Australia, is an ASX-listed public company.
- Following shareholder approval at the 24 June 2026 EGM, three directors acquired shares and options on 29 June 2026 under a loan agreement arrangement.
- Director Al Jawhari purchased 10 million ordinary shares and 5 million options exercisable at $0.02 until 29 June 2028 for $100,000; Arthur Stavrou acquired 2.5 million ordinary shares and 1.25 million options exercisable at $0.02 until the same expiry date for $25,000.
- The director interest notices were lodged late, breaching ASX Listing Rule timeframes due to administrative oversight; the company has reviewed procedures to avoid recurrence.
Shareholder Approval Enables Director Equity Issuance in June 2026
At the Extraordinary General Meeting on 24 June 2026, Papyrus Australia Limited secured shareholder approval to issue shares and options to its directors as part of a loan agreement. This approval facilitated a capital reorganisation culminating in the issuance of securities to directors on 29 June 2026, five days post-EGM. The issuance comprised ordinary shares and unlisted options with staggered exercise prices and expiry dates, designed to align directors’ interests with those of shareholders over a multi-year horizon.
The swift execution following shareholder consent underscores the company’s commitment to strategic equity decisions. The loan agreement structure enabled directors to invest while managing capital deployment, adhering to corporate governance standards and ensuring transparency with investors regarding material changes in director equity holdings.
Director Al Jawhari’s $100,000 Equity Investment and Position Expansion
Director Al Jawhari enhanced his indirect beneficial interests through Jewel Creek Ventures Pty Ltd, Greenway Ventures Pty Ltd, and Abdelshafel Ingy & Aljawhari Mohamed Allaa. On 29 June 2026, he acquired 10 million ordinary shares at $0.01 each, totaling $100,000, alongside 5 million options exercisable at $0.02 until 29 June 2028. This increased his total ordinary shares from 44,815,374 to 54,815,374, plus the new options. This significant increase signals strong confidence in Papyrus Australia’s medium-term prospects given the extended option exercise period.
Jawhari’s participation at the agreed pricing reflects terms set in the loan agreement. His acquisition, the largest among the directors, demonstrates substantial commitment and provides upside potential if the share price exceeds the $0.02 option exercise price within the two-year window. Combining immediate share ownership with deferred option rights aligns long-term incentives with shareholder value creation.
Arthur Stavrou’s $25,000 Investment and Option Portfolio Expansion
Director Arthur Stavrou, via Emilart Holdings Pty Ltd, acquired 2.5 million ordinary shares at $0.01 each for $25,000 on 29 June 2026, plus 1.25 million options exercisable at $0.02 until 29 June 2028. Prior to this, Stavrou held 800,000 ordinary shares, 2 million unlisted options exercisable at $0.01 expiring 19 March 2027, and 4 million unlisted options exercisable at $0.02 expiring 19 December 2027. Post-transaction, his holdings increased to 3.3 million ordinary shares and an additional tranche of 1.25 million options, consistent with terms granted to other directors.
While Stavrou’s investment was smaller than Jawhari’s, it remains a meaningful capital commitment. The multiple option tranches reflect ongoing participation in company financing and incentive schemes. The alignment of option pricing and expiry dates with other directors indicates uniformity in the loan agreement terms, reinforcing board confidence in the company’s strategic direction.
Late Filing of Director Interest Notices and Compliance Response
Papyrus Australia lodged the director interest change notices beyond the two-business-day window mandated by ASX Listing Rule 3.19A.2. The delay resulted from an administrative oversight, specifically the omission of Appendices 3Y filings following the 29 June share issuance. The oversight was identified during an internal review, after which the notices were promptly filed. Although the exact filing date relative to the transaction was not disclosed, the company acknowledged the breach and has taken steps to improve compliance.
This isolated incident highlights the necessity of robust administrative controls within the company’s share registry and company secretary functions. The transparent disclosure and remedial actions may reassure investors regarding Papyrus Australia’s commitment to corporate governance standards.
Brad Lemmon’s Director Interest Update and Share Acquisition
Brad Lemmon also participated in the 29 June 2026 share and option issuance under the loan agreement approved at the EGM. While his late Appendix 3Y notice was lodged alongside those of Jawhari and Stavrou, the announcement did not specify the details of his share acquisition, consideration, or total holdings. Investors seeking full information on Lemmon’s equity interests should consult the complete Appendix 3Y filings on the ASX website or contact the company directly.
Lemmon’s involvement confirms board alignment with the capital raising, and the collective participation of all three directors suggests the terms were viewed favorably and consistent with the company’s strategic goals. This coordinated director investment supports shareholder confidence in the EGM-approved transaction.
Loan Agreement Framework Supporting Director Share Issuance
The director share and option issuance was conducted under a loan agreement, as indicated in the director interest notices. However, specific loan details such as total amount, interest rates, repayment terms, or security were not disclosed. The $0.01 share price and $0.02 option exercise price reflected negotiated commercial terms within this framework, enabling directors to acquire equity while potentially easing immediate cash outflows.
Loan-backed equity participation is a common mechanism allowing directors to build substantial shareholdings while spreading financial commitments. The shareholder approval at the 24 June 2026 EGM underscores the materiality of the loan agreement and its terms. The absence of detailed loan disclosures limits investor insight into total indebtedness arising from this capital reorganisation.
Governance Enhancements and Internal Controls Strengthened
Following the late lodgement, Papyrus Australia reviewed and updated its internal procedures to ensure timely notification of director interest changes in compliance with ASX Listing Rules. The company described the administrative lapse as isolated and emphasized its commitment to improved governance. Best practices typically involve formal filing calendars, checklists, and staff training to prevent notification delays.
The company’s transparent disclosure and corrective measures demonstrate accountability and good regulatory engagement. However, specific procedural improvements were not detailed. Investors interested in governance enhancements may contact the company secretary for further information. This event underscores the importance of rigorous internal controls in managing ASX compliance obligations.
Director Shareholding Consolidation and Strategic Alignment
The June 2026 share issuance deepened equity stakes held by directors Jawhari, Stavrou, and Lemmon, reflecting shareholder endorsement of increased insider ownership. Director equity participation is widely regarded as a positive governance indicator, aligning management’s financial interests with those of shareholders. The modest pricing of $0.01 per share and $0.02 per option may reflect either a discount or prevailing market conditions at the EGM.
The multi-year option expiry to 29 June 2028 creates retention incentives encouraging long-term value creation. The unified director participation signals board confidence and commitment. For investors concerned about agency conflicts, this equity involvement provides assurance of aligned interests at the board level.
Investor Insights and Outlook
The disclosed director interest changes offer investors clarity on Papyrus Australia’s board equity structure. Jawhari’s holdings exceeding 54 million shares plus options suggest a controlling or near-controlling position. Stavrou’s meaningful stake also impacts voting power and governance considerations. The announcement did not specify any immediate share price impact from the issuance.
Investors should monitor Papyrus Australia’s financial and strategic developments, as well as future director dealings announcements, for ongoing signals of board confidence. The late lodgement, while addressed, highlights the need for vigilant governance. Reviewing the full Appendix 3Y filings is recommended for comprehensive director interest details. Key upcoming milestones include any option exercises from the 29 June 2026 issuance, which would further demonstrate director commitment to long-term shareholder value.
